Monopolar and Bipolar in Esophageal ESD

NCT ID: NCT05736705

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-23

Study Completion Date

2024-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to prospectively document the efficacy and clinical outcomes of Endoscopic Submucosal Dissection procedure that utilize either a novel Bipolar-Current ESD device or the standard monopolar electrocautery knife.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endoscopic submucosal dissection (ESD) is a novel technique for the removal of esophageal lesions or polyps with high-risk features. ESD is minimally invasive and allows the removal of esophageal polyps without resorting to morbid surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.

Traditionally, knifes utilizing monopolar current such as dual knife or hybrid knife were the preferred tools for endoscopic submucosal dissection. These knifes allows accurate dissection and excellent hemostasis. However, due to monopolar current generated heat, post coagulation syndrome can be seen in up to 8 to 40 % of patients. Post coagulation syndrome present with pain, fever and leukocytosis and requires supportive treatment with IV fluid and antibiotics. In addition, for large esophageal lesions, stricturing can occur after resection due to significant scar formation induced by large amounts of energy. Almost all patients with 60% of the esophageal circumference removed via monopolar knives, will develop an esophageal stricture at some point. These patients require serial esophageal dilations, and although easily managed, its development can be quite troublesome to the patient. Nevertheless, ESD is still the preferred modality for removal of these lesions, since it avoids the need for morbid surgery. Recently, a novel bipolar RFA knife were approved by FDA for the performance of ESD. The knife utilizes bipolar RFA current for submucosal dissection which can potentially expedite submucosal dissection and decrease the rates of post polypectomy syndrome and scar formation, by using significantly less energy. This bipolar knife may allow for removal of large esophageal lesions without causing major esophageal stricturing.

Our tertiary referral center Baylor St Luke's Medical Center is a center of excellence for ESD procedure and the investigators have previously reported our Esophageal ESD experience using the monopolar current knife. The goal of our protocol is to compare the performance of monopolar current cutting knife and bipolar RFA knife in esophageal endoscopic submucosal dissection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Neoplasm Esophageal Polyp Endoscopic Submucosal Dissection Bipolar Electocautery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two groups with patients randomized into receiving either the standard of care monopolar electrocautery tool or bipolar electrocautery tool.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
The patient will not know which electrocautery tool will be used in their procedure.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Monopolar Electrocautery tool

Patients randomized into this group will receive the standard of care monopolar tool for their endoscopic submucosal dissection procedure.

Group Type ACTIVE_COMPARATOR

Endoscopic Submucosal Dissection

Intervention Type PROCEDURE

Participants randomized in this arm will have the removal of their esophageal lesion utilizing the monopolar electrocautery knife.

Bipolar Electrocautery tool

Patients randomized into this group will receive the standard of care bipolar tool for their endoscopic submucosal dissection procedure.

Group Type EXPERIMENTAL

Endoscopic Submucosal Dissection

Intervention Type PROCEDURE

Participants randomized in this arm will have the removal of their esophageal lesion utilizing the monopolar electrocautery knife.

Bipolar electrocautery knife

Intervention Type DEVICE

Participants randomized in this arm will have the removal of their esophageal lesion utilizing the bipolar electrocautery knife.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic Submucosal Dissection

Participants randomized in this arm will have the removal of their esophageal lesion utilizing the monopolar electrocautery knife.

Intervention Type PROCEDURE

Bipolar electrocautery knife

Participants randomized in this arm will have the removal of their esophageal lesion utilizing the bipolar electrocautery knife.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ESD Mucosal Resection ESD Mucosal Resection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is ≥ 18 years old
* Patient is capable of providing informed consent
* Patient is referred for ESD procedure of an esophageal neoplastic lesion

Exclusion Criteria

* Patient is \< 18 years old
* Patient refused and/or unable to provide consent
* Patient is a pregnant woman
* Patients with lesions removed with other techniques besides ESD (i.e. cap EMR) or a modified ESD technique
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baylor College of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Salmaan Azam Jawaid, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baylor College of Medicine

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-52921

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Eso-Sponge Registry
NCT02662777 COMPLETED
EMR Versus ESD for Barrett's Neoplasia
NCT05276791 NOT_YET_RECRUITING NA
PULSed Field ablAtion of coloRectal Polyps
NCT06317727 NOT_YET_RECRUITING
a/LCI-OCT Pilot in Esophagus
NCT04392167 COMPLETED NA